Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pluviton is a multivitamin supplement developed and marketed by Meditec (MMeditech), an Israeli pharmaceutical company. It is primarily available as an oral solution, such as drops or syrup, and is indicated for the prevention and treatment of vitamin deficiencies, particularly in infants and children. The formulation typically includes a combination of essential micronutrients, including fat-soluble vitamins (Vitamin A and Vitamin D) and water-soluble vitamins (Vitamin C and B-complex vitamins like B1, B2, B3, and B6). These components support critical biological functions such as bone mineralization, immune system maintenance, and cellular energy metabolism. As a marketed consumer health product, it is used for nutritional support rather than as a prescription pharmaceutical for a specific disease pathology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pluviton.